30 Day Trial

Implanet Reports 2015 Revenue Up 6% vs. 2014

Share:

Implanet reported 2015 revenue of €6.6MM (~US $7.2MM), +6% vs. 2014 (excluding discontinued hip product sales). 

  • Spine ~$3.0MM, +45%
  • Knee & Arthroscopy ~$4.1MM, -11%

 

Spine growth for 2015 vs. 2014 was attributed to strong performance in distributor channels across all geographies:

  • U.S. ~$1.0MM, +47%
  • France ~$1.3MM, +47%
  • Rest of World ~$0.7MM, +41%

 

Quarter vs. quarter, the number of JAZZ spine surgical procedures grew +56% in 4Q15 vs. 4Q14.

Source: Implanet